This little-known genome editing stock is poised to surge more than 60%, JPMorgan says
According to analyst Eric Joseph, Beam is at the frontier of a rising theme for investors this year: therapeutics. Source
Read More
Beam Therapeutics Inc
Citi names its top biotech stock picks for 2023 — and gives one 73% upside
Biotech has been a "stock-pickers market" — and it may have just what it takes to remain one in 2023,
Read More
Here are Tuesday’s biggest analyst calls: Apple, Tesla, Hostess, Home Depot, Rivian, Netflix & more
Here are the biggest calls on Wall Street on Source link
Read More